• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 修饰写入器与肿瘤发展之间的串扰为指导胃癌个体化治疗提供依据。

Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer.

机构信息

Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Guangzhou Medical University, 250 Changgang East Road, Haizhu District, Guangzhou, 510260, Guangdong, China.

Department of Oncology, HaploX Biotechnology, Co., Ltd., Shenzhen, 518057, China.

出版信息

Hum Genomics. 2022 Apr 22;16(1):14. doi: 10.1186/s40246-022-00386-z.

DOI:10.1186/s40246-022-00386-z
PMID:35449086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9027049/
Abstract

BACKGROUND

Gastric cancer (GC) shows high metastasis and low survival. RNA modification writers play critical roles in tumor development. This study examined the clinical significance of RNA modification writers in GC prognosis based on four types of adenosine modifications (mA, mA, APA and A-to-I).

RESULTS

Writers demonstrated high mutation and expression in GC patients. Different expressions of 26 RNA modification writers were differentially associated with GC prognosis. High-WM score group appeared worse overall survival, higher immune infiltration and activation of EMT pathways than low-WM score group. WM score was correlated with both miRNAs-targeted signaling pathways and patients' sensitivity to chemotherapeutic drugs and efficacy of immunotherapy.

CONCLUSIONS

This study further revealed the close association between adenosine-related RNA modifications and progression of GC. A cross talk between EMT and RNA modification was identified to be one of the mechanisms underlying GC development. Our WM scoring system could serve as a clinical indicator for predicting GC prognosis. Importantly, the WM score could guide personalized treatments such as chemotherapy and immunotherapy for GC patients.

摘要

背景

胃癌(GC)具有高转移和低生存率的特点。RNA 修饰写入器在肿瘤发展中起着关键作用。本研究基于四种腺苷修饰(mA、mAm、APA 和 A-to-I),探讨了 RNA 修饰写入器在 GC 预后中的临床意义。

结果

在 GC 患者中,写入器表现出高突变和高表达。26 种 RNA 修饰写入器的不同表达与 GC 预后差异相关。高-WM 评分组的总生存期较差,免疫浸润和 EMT 途径的激活程度高于低-WM 评分组。WM 评分与 miRNA 靶向信号通路以及患者对化疗药物的敏感性和免疫治疗的疗效相关。

结论

本研究进一步揭示了腺苷相关 RNA 修饰与 GC 进展之间的密切关系。鉴定到 EMT 与 RNA 修饰之间的串扰是 GC 发展的机制之一。我们的 WM 评分系统可以作为预测 GC 预后的临床指标。重要的是,WM 评分可以指导 GC 患者的化疗和免疫治疗等个性化治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/7ef6b74760e3/40246_2022_386_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/fcfdb22138a6/40246_2022_386_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/0097cbca486b/40246_2022_386_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/3446b367b152/40246_2022_386_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/effa4b4f2f8b/40246_2022_386_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/06cc0a4f26c4/40246_2022_386_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/56c6644fd00c/40246_2022_386_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/5dd907d096d7/40246_2022_386_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/344acfa7f442/40246_2022_386_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/7ef6b74760e3/40246_2022_386_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/fcfdb22138a6/40246_2022_386_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/0097cbca486b/40246_2022_386_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/3446b367b152/40246_2022_386_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/effa4b4f2f8b/40246_2022_386_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/06cc0a4f26c4/40246_2022_386_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/56c6644fd00c/40246_2022_386_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/5dd907d096d7/40246_2022_386_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/344acfa7f442/40246_2022_386_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc7/9027049/7ef6b74760e3/40246_2022_386_Fig9_HTML.jpg

相似文献

1
Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer.RNA 修饰写入器与肿瘤发展之间的串扰为指导胃癌个体化治疗提供依据。
Hum Genomics. 2022 Apr 22;16(1):14. doi: 10.1186/s40246-022-00386-z.
2
Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.四种 RNA 修饰写入器的串扰定义了结直肠癌的肿瘤微环境和药物基因组学特征。
Mol Cancer. 2021 Feb 8;20(1):29. doi: 10.1186/s12943-021-01322-w.
3
Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer.RNA 修饰“书写器”的串扰描述了胃癌的肿瘤干性和微环境,并指导了胃癌的个性化免疫治疗。
Aging (Albany NY). 2023 Jun 14;15(12):5445-5481. doi: 10.18632/aging.204802.
4
RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy.RNA 修饰写入器影响胃癌肿瘤微环境和靶向药物治疗的前景。
J Bioinform Comput Biol. 2022 Apr;20(2):2250004. doi: 10.1142/S0219720022500044. Epub 2022 Mar 14.
5
A novel scoring model based on RNA modification "writers" can predict the prognosis and guide immunotherapy in gastric cancer.一种基于RNA修饰“书写者”的新型评分模型可预测胃癌预后并指导免疫治疗。
Funct Integr Genomics. 2023 May 16;23(2):162. doi: 10.1007/s10142-023-01098-w.
6
Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer.四种 RNA 修饰写入器的相互作用揭示了胰腺癌中独特的肿瘤微环境和生物学特征。
Front Immunol. 2022 Dec 19;13:1031184. doi: 10.3389/fimmu.2022.1031184. eCollection 2022.
7
RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.RNA 修饰“写入器”介导的 RNA 修饰模式与宫颈癌肿瘤微环境特征。
Clin Transl Oncol. 2022 Jul;24(7):1413-1424. doi: 10.1007/s12094-022-02787-x. Epub 2022 Feb 27.
8
Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.m6A 读写器和擦除器在胃癌中的表达谱和预后作用。
Future Oncol. 2021 Jul;17(20):2605-2620. doi: 10.2217/fon-2020-0630. Epub 2021 Apr 21.
9
Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.肝细胞癌中 RNA 甲基化修饰的临床意义及靶向景观的综合研究。
Eur J Med Res. 2023 Jan 27;28(1):46. doi: 10.1186/s40001-023-01016-7.
10
A new risk model based on a 11-mA-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer.一种基于与 11-mA 相关的长链非编码 RNA 特征的新型风险模型,用于预测胃癌的预后和监测免疫治疗。
BMC Cancer. 2022 Apr 5;22(1):365. doi: 10.1186/s12885-021-09062-2.

引用本文的文献

1
Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer.四种腺嘌呤相关 RNA 修饰写入器介导的分子亚型有助于预测膀胱癌的临床结局和治疗选择。
Front Immunol. 2023 Aug 11;14:1152806. doi: 10.3389/fimmu.2023.1152806. eCollection 2023.
2
Identification and validation of RNA methylation-related alternative splicing gene signature for low-grade glioma to predict survival and immune landscapes.用于预测低级别胶质瘤生存和免疫格局的RNA甲基化相关可变剪接基因特征的鉴定与验证
J Cancer Res Clin Oncol. 2023 Jan;149(1):47-62. doi: 10.1007/s00432-022-04431-1. Epub 2022 Dec 18.

本文引用的文献

1
Suppression of CPSF6 Enhances Apoptosis Through Alternative Polyadenylation-Mediated Shortening of the 3'UTR in Gastric Cancer Cells.抑制CPSF6通过可变聚腺苷酸化介导的胃癌细胞3'非翻译区缩短增强细胞凋亡。
Front Genet. 2021 Sep 14;12:707644. doi: 10.3389/fgene.2021.707644. eCollection 2021.
2
METTL3-mediated mA mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.METTL3介导的m⁶A mRNA修饰通过Notch信号通路促进食管癌的发生和发展。
Mol Ther Nucleic Acids. 2021 Jul 21;26:333-346. doi: 10.1016/j.omtn.2021.07.007. eCollection 2021 Dec 3.
3
The RNA m6A writer METTL14 in cancers: Roles, structures, and applications.
RNA m6A 写入酶 METTL14 在癌症中的作用、结构和应用。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188609. doi: 10.1016/j.bbcan.2021.188609. Epub 2021 Aug 8.
4
Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.用于预测胃癌总生存期的EMT相关基因特征的鉴定
Front Genet. 2021 Jun 24;12:661306. doi: 10.3389/fgene.2021.661306. eCollection 2021.
5
The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.与预后和免疫治疗反应相关的上皮-间质转化与免疫逃逸之间串扰的泛癌格局。
NPJ Precis Oncol. 2021 Jun 22;5(1):56. doi: 10.1038/s41698-021-00200-4.
6
DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer.DNA甲基化调节因子介导的胃癌修饰模式及肿瘤微环境特征
Mol Ther Nucleic Acids. 2021 Apr 3;24:695-710. doi: 10.1016/j.omtn.2021.03.023. eCollection 2021 Jun 4.
7
Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.m6A 读写器和擦除器在胃癌中的表达谱和预后作用。
Future Oncol. 2021 Jul;17(20):2605-2620. doi: 10.2217/fon-2020-0630. Epub 2021 Apr 21.
8
Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.四种 RNA 修饰写入器的串扰定义了结直肠癌的肿瘤微环境和药物基因组学特征。
Mol Cancer. 2021 Feb 8;20(1):29. doi: 10.1186/s12943-021-01322-w.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
m A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy.m6A 甲基转移酶 METTL3/14 调控抗 PD-1 治疗的免疫应答。
EMBO J. 2020 Oct 15;39(20):e104514. doi: 10.15252/embj.2020104514. Epub 2020 Sep 23.